Government ContextGovernment Context
TopicsAgenciesOrganizationsDocumentsPricingLog inCreate account
TopicsAgenciesOrganizationsDocumentsPricing
LoginCreate account
Organizations › Genentech
G

Genentech

Business/org/genentech
Comments
2
Dockets
2
Lobbying · 2025
$280K
Support
2
Oppose
0

Activity

No recent organization activity yet. Historical comments remain available in the record.

Lobbying

5 current filings

OOgrSince Jan 2026 · HCR$70KM&Marshall & PoppSince Jan 2026 · CPT, PHA, TRD$60KCCCapitol CounselSince Jan 2026 · HCR, MMM$50KCGCornerstone Government AffairsSince Jan 2026 · BUD, HCR$50KFForbes-TateSince Jan 2026 · BUD, CPT, HCR, MAN, MMM, TAX$50K

Comment record

Recent public comments attributed to this organization.

  • Medicare and Medicaid Programs: Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, etc.
    Jun 29Support
  • General Considerations for the Use of New Approach Methodologies in Drug Development; Guidance for Industry - Draft Guidance
    May 20Support
Government ContextGovernment Context

Track federal rulemaking documents, topics, and agencies — built on primary sources across the federal government.

ExploreDocumentsTopicsAgenciesOrganizations
CompanyAboutData sourcesPricing
LegalPrivacyTerms
© 2026 Government Context. Built on primary government sources.Not affiliated with any U.S. government agency.